4//SEC Filing
Sauer Paul 4
Accession 0001209191-22-031865
CIK 0001649094other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 4:24 PM ET
Size
5.3 KB
Accession
0001209191-22-031865
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Sauer Paul
SVP Process Dev, Manufacturing
Transactions
- Sale
Common Stock
2022-05-23$26.22/sh−3,000$78,671→ 23,687 total
Footnotes (3)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported is a weighted-average price. The shares were sold at prices ranging from $25.72 to $26.61. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Includes 1,562 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on May 17, 2022.
Documents
Issuer
Vaxcyte, Inc.
CIK 0001649094
Entity typeother
Related Parties
1- filerCIK 0001813796
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 4:24 PM ET
- Size
- 5.3 KB